Patients with inflammatory bowel disease (IBD) have been reported to have an increased risk of thromboembolism. Cerebral venous thrombosis (CVT) is a rare but serious extraintestinal manifestation of IBD. Due to its highly variable manifestation and low incidence, CVT is not usually readily recognized by physicians. Herein, we report a case of a 35-year-old male presenting with CVT associated with ulcerative colitis (UC). The patient was admitted with chief complaints of bloody diarrhea that had started 3 days prior. Sigmoidoscopy showed hyperemic and edematous mucosa, friability, and shallow ulcers from the sigmoid colon to the rectum suggestive of IBD. Three days later, the patient started complaining of a headache, and gradually developed a decreased level of consciousness. Magnetic resonance imaging of the brain revealed CVT with hemorrhagic infarctions. An angiogram was obtained to evaluate the extent of CVT, and anticoagulation therapy was initiated with intravenous heparin. During hospitalization, he was diagnosed with UC and treated with 5-aminosalicylic acid. After discharge, the patient was recovered without neurological deficit, and remission of UC was also obtained. The presence of headache or acute worsening of neurological status in a patient with IBD should alert the health professionals about the possibility of CVT.

Citations

Citations to this article as recorded by  

• Digit Necrosis After Hand Surgery in Pregnancy: A Case Report
  Natalia Ziolkowski, Jana Dengler, Cory S Goldberg
  Plastic Surgery Case Studies.2021;[Epub]     CrossRef
• Cerebral venous thrombosis as presenting manifestation of inflammatory bowel disease (IBD)
  Katie Stamp, Alison Pattinson, Paul Maliakal, Thekootu Nandakumar, Shaji Sebastian
  GastroHep.2019; 1(1): 45.     CrossRef

Approximately one-third of patients with Crohn's disease do not respond to conventional treatments, and some experience significant adverse effects, such as serious infections and lymphoma, and many patients require surgery due to complications. Increasing evidence suggests that specific changes in the composition of gut microbiota, termed as dysbiosis, are a common feature in patients with inflammatory bowel disease (IBD). Dysbiosis can lead to activation of the mucosal immune system, resulting in chronic inflammation and the development of mucosal lesions. Recently, fecal microbiota transplantation, aimed at modifying the composition of gut microbiota to overcome dysbiosis, has become a potential alternative therapeutic option for IBD. Herein, we present a patient with Crohn's colitis in whom biologic therapy failed previously, but clinical remission and endoscopic improvement was achieved after a single fecal microbiota transplantation infusion.

Citations

Citations to this article as recorded by  

• Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn’s disease
  Yao Xu, Runxiang Xie, Yuqing Weng, Yewei Fang, Shuan Tao, He Zhang, Huimin Chen, Axiang Han, Qi Jiang, Wei Liang
  International Journal of Colorectal Disease.2025;[Epub]     CrossRef
• Epigenetics and the role of nutraceuticals in health and disease
  Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
  Environmental Science and Pollution Research.2023; 30(11): 28480.     CrossRef
• Crohn’s disease: Etiology, pathogenesis and treatment strategies
  Izel Aycan BASOGLU, Berna KARAKOYUN
  Marmara Medical Journal.2023; 36(2): 249.     CrossRef
• Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
  Eva Michaud, Louis Waeckel, Rémi Gayet, Roman Goguyer‐Deschaumes, Blandine Chanut, Fabienne Jospin, Katell Bathany, Magali Monnoye, Coraline Genet, Amelie Prier, Caroline Tokarski, Philippe Gérard, Xavier Roblin, Nicolas Rochereau, Stéphane Paul
  EMBO Molecular Medicine.2022;[Epub]     CrossRef
• Gut microbiota: A new target for T2DM prevention and treatment
  Lulu Liu, Jiheng Zhang, Yi Cheng, Meng Zhu, Zhifeng Xiao, Guangcong Ruan, Yanling Wei
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
  Cátia Almeida, Rita Oliveira, Pilar Baylina, Rúben Fernandes, Fábio G. Teixeira, Pedro Barata
  Biomedicines.2022; 10(11): 2742.     CrossRef
• Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
  Fengwei Zhang, Peilin Yang, Yilin Chen, Ruirui Wang, Baocheng Liu, Jianying Wang, Min Yuan, Lei Zhang
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis
  F. Cheng, Z. Huang, W. Wei, Z. Li
  Techniques in Coloproctology.2021; 25(5): 495.     CrossRef
• Management of Clostridioides difficile infection in patients with inflammatory bowel disease
  Sahil Khanna
  Intestinal Research.2021; 19(3): 265.     CrossRef
• Microbiota and epigenetics: promising therapeutic approaches?
  Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
  Environmental Science and Pollution Research.2021; 28(36): 49343.     CrossRef
• Improving the Gut Microbiota with Probiotics and Faecal Microbiota Transplantation
  Yogita M. Patil, Rajashree B. Patwardhan, Pragati S. Abhyankar
  Journal of Pure and Applied Microbiology.2021; 15(3): 1111.     CrossRef
• Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
  Yonghyun Lee, Nobuhiko Kamada, James J. Moon
  Advanced Drug Delivery Reviews.2021; 179: 114021.     CrossRef
• Alteration of Gut Microbiota in Autism Spectrum Disorder: An Overview
  Donghun Oh, Keun-Ah Cheon
  Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 131.     CrossRef
• Development of the Korean Form of the Premonitory Urge for Tics Scale: A Reliability and Validity Study
  Mira Kim, Sang-Keun Chung, Jong-Chul Yang, Jong-Il Park, Seok Hyun Nam, Tae Won Park
  Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 146.     CrossRef
• Secondary causes of inflammatory bowel diseases
  Yezaz A Ghouri, Veysel Tahan, Bo Shen
  World Journal of Gastroenterology.2020; 26(28): 3998.     CrossRef
• Fecal microbiota transplantation in the treatment of Crohn disease
  Miranda Collins, Morgan DeWitt
  JAAPA.2020; 33(9): 34.     CrossRef
• Inflammatory Bowel Diseases: The Role of Gut Microbiota
  Cristiana De Musis, Lucia Granata, Marcello Dallio, Agnese Miranda, Antonietta G. Gravina, Marco Romano
  Current Pharmaceutical Design.2020; 26(25): 2951.     CrossRef
• The human-microbiome superorganism and its modulation to restore health
  E. Salvucci
  International Journal of Food Sciences and Nutrition.2019; 70(7): 781.     CrossRef
• The microbiome, cancer, and cancer therapy
  Beth A. Helmink, M. A. Wadud Khan, Amanda Hermann, Vancheswaran Gopalakrishnan, Jennifer A. Wargo
  Nature Medicine.2019; 25(3): 377.     CrossRef
• RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
  Jung Hoon Song, You Sun Kim
  Gut and Liver.2019; 13(1): 16.     CrossRef
• Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
  Michael Kriss, Keith Z Hazleton, Nichole M Nusbacher, Casey G Martin, Catherine A Lozupone
  Current Opinion in Microbiology.2018; 44: 34.     CrossRef
• Microbiota transplantation: concept, methodology and strategy for its modernization
  Faming Zhang, Bota Cui, Xingxiang He, Yuqiang Nie, Kaichun Wu, Daiming Fan
  Protein & Cell.2018; 9(5): 462.     CrossRef
• The hygiene hypothesis at a glance: Early exposures, immune mechanism and novel therapies
  Gabriel M. Alexandre-Silva, Pablo A. Brito-Souza, Ana C.S. Oliveira, Felipe A. Cerni, Umberto Zottich, Manuela B. Pucca
  Acta Tropica.2018; 188: 16.     CrossRef
• The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
  Honggang Wang, Bota Cui, Qianqian Li, Xiao Ding, Pan Li, Ting Zhang, Xiaozhong Yang, Guozhong Ji, Faming Zhang
  Advances in Therapy.2018; 35(11): 1935.     CrossRef
• Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
  Chang Soo Eun
  Intestinal Research.2017; 15(2): 145.     CrossRef
• Diagnosis and treatment of Crohn's disease
  Hyun-Soo Kim
  Journal of the Korean Medical Association.2017; 60(6): 484.     CrossRef